Who should take aspirin for primary prophylaxis of coronary heart disease?

Heart. 2001 Mar;85(3):245-6. doi: 10.1136/heart.85.3.245.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aspirin / adverse effects
  • Aspirin / therapeutic use*
  • Cardiovascular Diseases / prevention & control
  • Coronary Disease / prevention & control*
  • Hemorrhage / chemically induced
  • Humans
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Primary Prevention
  • Risk Assessment

Substances

  • Platelet Aggregation Inhibitors
  • Aspirin